Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

entrectinib 2venetoclax 1trametinib 1tazemetostat 1sodium thiosulfate 1selpercatinib 1ripretinib 1repotrectinib 1pirtobrutinib 1pembrolizumab 1nirogacestat 1larotrectinib 1dabrafenib 1avapritinib 1atezolizumab 1Taxes 1Specimen Handling 1Rituximab 1Restraint, Physical 1Paclitaxel 1Immunoglobulin G 1Disulfides 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × ripretinib × Sarcoma × Clear all
NCT03353753 2022-11-21

INVICTUS

Deciphera Pharmaceuticals, LLC

Phase 3 Completed
129 enrolled 19 charts 1 FDA
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡